Literature DB >> 1014299

Oestrogen receptors in feline mammary carcinomas.

J M Hamilton, R W Else, P Forshaw.   

Abstract

Twenty primary or metastatic felline mammary tumours were assayed for the presence of oestrogen receptors by the dextran-coated charcoal method. In only two of the tumours was the presence of specific oestrogen binding protein demonstrable. The high negative rate in comparison with human and canine mammary tumours assayed under similar conditions seemed to be a peculiar feature of the feline tumours and suggested a lack of oestrogen dependency. The possibility remains that other hormones may be concerned with the growth of feline mammary tumours and further work is in progress.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1014299     DOI: 10.1136/vr.99.24.477

Source DB:  PubMed          Journal:  Vet Rec        ISSN: 0042-4900            Impact factor:   2.695


  5 in total

1.  Feline mammary carcinoma: a retrospective evaluation of 17 cases.

Authors:  M J Tomlinson; L Barteaux; L E Ferns; E Angelopoulos
Journal:  Can Vet J       Date:  1984-12       Impact factor: 1.008

Review 2.  Animal model of human disease: breast cancer.

Authors:  W Misdorp; K Weijer
Journal:  Am J Pathol       Date:  1980-02       Impact factor: 4.307

3.  Progesterone receptors in feline mammary cancer cytosol.

Authors:  H Elling; F R Ungemach
Journal:  J Cancer Res Clin Oncol       Date:  1981       Impact factor: 4.553

4.  Animal models for hormone-dependent human breast cancer. Relationship between steroid receptor profiles in canine and feline mammary tumors and survival rate.

Authors:  P M Martin; M Cotard; J P Mialot; F André; J P Raynaud
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

5.  Feline mammary basal-like adenocarcinomas: a potential model for human triple-negative breast cancer (TNBC) with basal-like subtype.

Authors:  David A Wiese; Tuddow Thaiwong; Vilma Yuzbasiyan-Gurkan; Matti Kiupel
Journal:  BMC Cancer       Date:  2013-09-03       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.